Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Pandemic's hidden toll: study probes youth suicide surge

NCT ID NCT07302295

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study examines the clinical and socioeconomic factors linked to suicidal behavior in children and adolescents during the COVID-19 pandemic in the Auvergne-Rhône-Alpes region of France. Researchers will collect data from 6,500 participants aged 8 to 17, including medical records and interviews, to understand how lockdowns and social restrictions impacted mental health. The goal is to identify patterns and risk factors to better prevent future tragedies.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this study could help identify risk factors and improve prevention strategies for youth suicide during health crises.
What could go wrong
This is an observational study, not a treatment trial. It cannot prove cause and effect, and results may not apply to other regions or future pandemics.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 6,500 people

The number the study aims to enrol. It can still change while the study runs.

Started

May 2026

Expected to finish

Feb 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

8 to 18 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * The population (subjects and controls) will be divided into age categories: * Pre-adolescents (≥ 8 years and \< 11 years) * Adolescents (≥ 11 years and \< 15 years) * Older adolescents (≥ 15 years and \< 18 years) Subjects with suicidal behavior during the health crisis (Group 1): * Age \> 8 years and \< 18 years during the period 2020 to 2022. * Admitted to pediatric emergency departments or hospitalized in a care unit (CHU, general hospitals) in the AURA region during 2020, 2021, and/or 2022 for suicidal behavior (defined as suicidal ideation and/or suicide attempt and/or self-harm/self-poisoning with suicidal intent). Subjects with suicidal behavior during the health crisis with qualitative interviews (Group 1b): * Age \> 8 years and \< 18 years during the period 2020 to 2022. * Admitted to pediatric emergency departments or hospitalized in a care unit (CHU, general hospitals) in the AURA region during 2020, 2021, and/or 2022 for suicidal behavior (defined as suicidal ideation and/or suicide attempt and/or self-harm/self-poisoning with suicidal intent). * Randomly selected from the population of Group 1. * For whom the parent(s) and/or the subject have signed informed consent. Controls with suicidal behavior before the health crisis (Group 2): * Age \> 8 years and \< 18 years during the period 2018 to 2019. * Admitted to pediatric emergency departments or hospitalized in a care unit (CHU, general hospitals) in the AURA region during 2018 and/or 2019 for suicidal behavior (defined as suicidal ideation and/or suicide attempt and/or self-harm/self-poisoning with suicidal intent). Exclusion Criteria: \- Subjects with Suicidal Behavior during the Health Crisis with and without Qualitative Interviews (Group 1 and 1b): • Admitted to pediatric emergency services or hospitalized in a healthcare facility (university hospital center, general hospital) in the AURA region for a psychiatric reason other than suicidal behavior during the period from 2020 to 2022. Controls with Suicidal Behavior before the Health Crisis (Group 2): * Admitted to pediatric emergency services or hospitalized in a healthcare facility (university hospital center, general hospital) in the AURA region for a psychiatric reason other than suicidal behavior during the period from 2018 to 2019. * Intercurrent illness with a life expectancy of less than 24 hours. For Group 1: * Pregnant, postpartum, or breastfeeding women. * Persons deprived of liberty by judicial or administrative decision. * Adults subject to a legal protection measure (guardianship, curatorship). * Persons not affiliated with a social security scheme or beneficiaries of a similar scheme. * Persons who do not understand and do not speak French.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COVID -19 are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

COVID-19 Suicidal Ideation Suicide

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    4 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • CHU de Clermont-Ferrand - Service de psychiatrie de l'enfant et de l'adolescent

    NOT_YET_RECRUITING

    Clermont-Ferrand, 63000, France

  • CHU de Grenoble - Service de psychiatrie de l'enfant et de l'adolescent

    NOT_YET_RECRUITING

    Grenoble, 38043, France

  • CHU de Saint-Etienne - Urgences psychiatriques

    NOT_YET_RECRUITING

    Saint-Etienne, 42100, France

  • Hospices Civils de Lyon - Hôpital Femme Mère Enfant- Service de pédopsychiatrie de l'enfant et de l'adolescent

    RECRUITING

    Bron, 69500, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.